Sylvie Rusakiewicz

10.4k total citations
44 papers, 1.4k citations indexed

About

Sylvie Rusakiewicz is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sylvie Rusakiewicz has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Sylvie Rusakiewicz's work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (16 papers). Sylvie Rusakiewicz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (16 papers). Sylvie Rusakiewicz collaborates with scholars based in France, Switzerland and United States. Sylvie Rusakiewicz's co-authors include Laurence Zitvogel, Guido Kroemer, Aurélien Marabelle, Jean‐Charles Soria, Sophie Postel‐Vinay, Sandrine Aspeslagh, Maha Ayyoub, Bertrand Routy, Michaëla Semeraro and J. Alejandro Madrigal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Sylvie Rusakiewicz

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Rusakiewicz France 22 800 800 322 168 118 44 1.4k
Inmaculada Rodríguez Spain 19 1.0k 1.3× 991 1.2× 285 0.9× 113 0.7× 88 0.7× 24 1.5k
Jingwei Sun China 11 717 0.9× 753 0.9× 438 1.4× 193 1.1× 109 0.9× 22 1.3k
Ehsan Ghorani United Kingdom 14 731 0.9× 534 0.7× 431 1.3× 152 0.9× 222 1.9× 31 1.3k
Frank M. Speetjens Netherlands 20 617 0.8× 613 0.8× 326 1.0× 137 0.8× 87 0.7× 50 1.1k
Jan L. Fisher United States 20 703 0.9× 825 1.0× 412 1.3× 96 0.6× 80 0.7× 37 1.3k
Laura Ridolfi Italy 20 1.2k 1.5× 877 1.1× 463 1.4× 309 1.8× 110 0.9× 67 1.6k
Masahiro Kashiwaba Japan 16 877 1.1× 972 1.2× 642 2.0× 166 1.0× 236 2.0× 46 1.7k
Michelle C.R. Yong Australia 16 982 1.2× 834 1.0× 209 0.6× 254 1.5× 87 0.7× 18 1.5k
Jesse M. Zaretsky United States 8 1.5k 1.9× 1.3k 1.7× 518 1.6× 278 1.7× 183 1.6× 16 2.1k
Michelle R. Padget United States 15 724 0.9× 579 0.7× 267 0.8× 85 0.5× 75 0.6× 22 1.0k

Countries citing papers authored by Sylvie Rusakiewicz

Since Specialization
Citations

This map shows the geographic impact of Sylvie Rusakiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Rusakiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Rusakiewicz more than expected).

Fields of papers citing papers by Sylvie Rusakiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Rusakiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Rusakiewicz. The network helps show where Sylvie Rusakiewicz may publish in the future.

Co-authorship network of co-authors of Sylvie Rusakiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Rusakiewicz. A scholar is included among the top collaborators of Sylvie Rusakiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Rusakiewicz. Sylvie Rusakiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dutta, Devanjali, L. Francisco Lorenzo‐Martín, François Rivest, et al.. (2024). Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids. npj Precision Oncology. 8(1). 179–179. 1 indexed citations
2.
Morfouace, Marie, Daniel Schulz, Nils Eling, et al.. (2023). 2266P IMMUcan consortium: Focus on the first results of the non-small cell lung cancer (NSCLC) cohort. Annals of Oncology. 34. S1164–S1164. 2 indexed citations
3.
Chong, Chloé, Florian Huber, HuiSong Pak, et al.. (2023). The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. Nature Cancer. 4(5). 608–628. 48 indexed citations
4.
Gavrielatou, Niki, Aris Spathis, Μaria Anastasiou, et al.. (2023). B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma. Annals of Oncology. 35(4). 340–350. 29 indexed citations
5.
Mark, Michael, Sylvie Rusakiewicz, Martin Früh, et al.. (2022). Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. ESMO Open. 7(3). 100446–100446. 5 indexed citations
6.
Charrier, Mélinda, Laura Mezquita, B. Lueza, et al.. (2019). Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients. European Journal of Cancer. 108. 88–96. 34 indexed citations
7.
Colombo, Marina, Meriem Messaoudene, Sylvie Rusakiewicz, et al.. (2017). Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib. Cancer Immunology Research. 5(7). 582–593. 18 indexed citations
8.
Messaoudene, Meriem, Giulia Fregni, David Enot, et al.. (2016). NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution. OncoImmunology. 5(12). e1154251–e1154251. 20 indexed citations
9.
Aspeslagh, Sandrine, Sophie Postel‐Vinay, Sylvie Rusakiewicz, et al.. (2015). Rationale for anti-OX40 cancer immunotherapy. European Journal of Cancer. 52. 50–66. 248 indexed citations
10.
Andrade, Lucas Ferrari de, Shin Foong Ngiow, Kimberley Stannard, et al.. (2014). Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma. Cancer Research. 74(24). 7298–7308. 81 indexed citations
11.
Messaoudene, Meriem, Giulia Fregni, J. Chanal, et al.. (2013). Mature Cytotoxic CD56bright/CD16 + Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma. Cancer Research. 74(1). 81–92. 79 indexed citations
12.
Goèré, Diane, Caroline Flament, Sylvie Rusakiewicz, et al.. (2013). Potent Immunomodulatory Effects of the Trifunctional Antibody Catumaxomab. Cancer Research. 73(15). 4663–4673. 34 indexed citations
13.
Chaput, Nathalie, Caroline Flament, Clara Locher, et al.. (2013). Phase I clinical trial combining imatinib mesylate and IL-2. OncoImmunology. 2(2). e23080–e23080. 23 indexed citations
14.
Desbois, Mélanie, Sylvie Rusakiewicz, Clara Locher, Laurence Zitvogel, & Nathalie Chaput. (2012). Natural killer cells in non-hematopoietic malignancies. Frontiers in Immunology. 3. 395–395. 22 indexed citations
15.
Rusakiewicz, Sylvie, Magalie Dosset, Karine Mollier, et al.. (2010). Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice. Vaccine. 28(38). 6374–6381. 10 indexed citations
16.
Rusakiewicz, Sylvie, Carmen Marchiol, Léa Tourneur, et al.. (2009). Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response. Cancer Immunology Immunotherapy. 58(10). 1669–1677. 26 indexed citations
17.
Tuthill, Mark, Frederick Chen, Samantha Paston, et al.. (2009). The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation. Cancer Immunology Immunotherapy. 58(9). 1481–1488. 14 indexed citations
18.
Rusakiewicz, Sylvie, J. Alejandro Madrigal, Paul Travers, & Anthony I. Dodi. (2009). BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donors. Cancer Immunology Immunotherapy. 58(9). 1449–1457. 13 indexed citations
19.
Locher, Clara, Sylvie Rusakiewicz, Antoine Tesnière, et al.. (2009). Witch Hunt against Tumor Cells Enhanced by Dendritic Cells. Annals of the New York Academy of Sciences. 1174(1). 51–60. 10 indexed citations
20.
Rusakiewicz, Sylvie & Jeffrey J. Molldrem. (2006). Immunotherapeutic peptide vaccination with leukemia-associated antigens. Current Opinion in Immunology. 18(5). 599–604. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inmaculada Rodríguez Breakdown of academic impact, for papers by Jingwei Sun Breakdown of academic impact, for papers by Ehsan Ghorani Breakdown of academic impact, for papers by Frank M. Speetjens Breakdown of academic impact, for papers by Jan L. Fisher Breakdown of academic impact, for papers by Laura Ridolfi Breakdown of academic impact, for papers by Masahiro Kashiwaba Breakdown of academic impact, for papers by Michelle C.R. Yong Breakdown of academic impact, for papers by Jesse M. Zaretsky Breakdown of academic impact, for papers by Michelle R. Padget
Rankless by CCL
2026